Hepatitis C and the correctional population

American Journal of Medicine

Volumn 107, Issue 6 SUPPL. 2, 1999, Pages 100-103

  Reindollar, Robert W ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; HEPATITIS C; HUMAN; INTRAVENOUS DRUG ABUSE; PRIORITY JOURNAL; PRISON; RISK FACTOR; SEROCONVERSION; SEXUAL BEHAVIOR; SOCIAL ENVIRONMENT; UNITED STATES;

EID: 0033378310     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(99)00394-0     Document Type: Conference Paper

References (16)

1. NIH News Release. Washington, DC: National Institutes of Health, 1998. National Institutes of Health publication NIDA Press 301-443-6345.
2. Data on file, United States Department of Justice, Bureau of Justice Statistics, 1998.
3. Alter M.J. Epidemiology of hepatitis C. Hepatology. 26:1997;62S-65S.
4. National Institutes of Health. Chronic hepatitis C: current disease management. Washington, DC: National Digestive Diseases Clearinghouse; 1998. National Institutes of Health publication NIH 97-4230.
5. Vlahov D., Nelson K.E., Quinn T.C., Kendig N. Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. Eur J Epidemiol. 9:1993;566-569.
6. Data on file, California Department of Health Services, Office of AIDS, 1996.
7. Ford P.M., White C., Kaufman H., et al. Voluntary anonymous linked study of the prevalence of HIV infection and hepatitis C among inmates in a Canadian federal penitentiary for women. CMAJ. 153:1995;1605-1609.
8. Pinducciu G., Arnone M., Piu G., et al. Prevalence of hepatitis virus (HBV and HCV) and HIV-1 infections in a prison community. Ann Ig. 2:1990;359-363.
9. Nara K., Kawano M., Igarashi M. Prevalence of hepatitis C virus and human immunodeficiency virus infection among female prison inmates in Japan. Nippon Koshu Eisei Zasshi. 44:1997;55-60.
10. Crofts N., Stewart T., Hearne P., Ping X.Y., Breshkin A.M., Locarnini S.A. Spread of blood borne viruses among Australian prison entrants. BMJ. 310:1995;285-288.
11. Holsen D.S., Harthug S., Myrmel H. Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway. Eur J Clin Microbiol Inf Dis. 12:1993;673-676.
12. Seroprevalence of hepatitis C virus infection at the time of entry to prison in the prison population in the north-east of Spain [in Spanish]. Rev Esp Salud Publica. 1998;72:43-51.
13. Butler T.G., Dolan K.A., Ferson M.J., McGuinness L.M., Brown P.R., Robertson P.W. Hepatitis B and C in New South Wales prisons prevalence and risk factors . Med J Aust. 166:1997;127-130.
14. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR. 47:1998;1-39.
15. National Institutes of Health. Management of hepatitis C. NIH consensus statement online. 1997;15:1-41.
16. Data on file, United States Government, National Commission on Correctional Health Care, 1999.